Osteoarthritis is associated with increased failure of proximal femoral fracture fixation.


Journal

International orthopaedics
ISSN: 1432-5195
Titre abrégé: Int Orthop
Pays: Germany
ID NLM: 7705431

Informations de publication

Date de publication:
05 2019
Historique:
received: 24 01 2017
accepted: 04 06 2018
pubmed: 22 6 2018
medline: 7 2 2020
entrez: 22 6 2018
Statut: ppublish

Résumé

The purpose of this study was to evaluate whether the presence of hip osteoarthritis at the time of hip fracture increases treatment failure rates when using either a sliding hip screw (SHS) or proximal femoral nail (PFN) for fracture fixation. A retrospective study of a consecutive series of 455 women and 148 men (median age, 83.8 years) treated with SHS or PFN was performed. Osteoarthritis was evaluated based on pre-operative radiographs using the Kellgren and Lawrence grading system. Treatment failure, which was defined as non-union, avascular necrosis, backing out of the implant, cut out of the proximal screws, peri-prosthetic fracture, implant breakage, or conversion to hemi- or total hip arthroplasty, was evaluated for a follow-up period of four to seven years. Optimal placement of the implant (tip-apex distance (TAD) and 3-point fixation) and the effects of age, sex, the quality of reduction, implant type, fracture stability, fracture type, and time to failure were considered confounders of the relationship between failure and osteoarthritis (OA). Among the 32 cases (5.3%) of treatment failure, 12 (2%) showed evidence of osteoarthritis. After controlling for age, sex, the quality of reduction, implant type, fracture stability, fracture type, and TAD, osteoarthritis was associated a greater than threefold increase in treatment failure compared with that of patients without pre-operative evidence of osteoarthritis (OR, 3.26; 95% CI, 1.4-7.65; P = 0.006). After adjusting for potential confounding factors, radiographic evidence of hip osteoarthritis at the time of hip fracture increases the incidence of treatment failure.

Identifiants

pubmed: 29926148
doi: 10.1007/s00264-018-4014-8
pii: 10.1007/s00264-018-4014-8
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1223-1230

Références

J Orthop Trauma. 2016 Mar;30(3):125-9
pubmed: 26894639
Bone Joint J. 2013 Jun;95-B(6):825-30
pubmed: 23723280
Osteoporos Int. 2016 Feb;27(2):549-58
pubmed: 26286626
J Bone Joint Surg Br. 1990 Jan;72(1):26-31
pubmed: 2298790
Injury. 2007 Sep;38 Suppl 3:S24-34
pubmed: 17723789
Int Orthop. 2010 Dec;34(8):1273-6
pubmed: 19784649
Bone. 1993;14 Suppl 1:S51-6
pubmed: 8110521
J Orthop Trauma. 2018 Jan;32 Suppl 1:S1-S170
pubmed: 29256945
BMC Musculoskelet Disord. 2010 Nov 26;11:274
pubmed: 21110879
Arch Orthop Trauma Surg. 2016 May;136(5):623-30
pubmed: 26852380
Chin Med J (Engl). 2016 5th Nov;129(21):2630-2638
pubmed: 27779172
BMC Musculoskelet Disord. 2010 Jun 26;11:133
pubmed: 20579384
Int Orthop. 2010 Jun;34(5):719-22
pubmed: 19618186
Int Orthop. 2006 Apr;30(2):69-78
pubmed: 16496147
Curr Orthop Pract. 2016 Nov-Dec;27(6):604-613
pubmed: 28348717
Injury. 2008 Oct;39(10):1157-63
pubmed: 18653186
Osteoarthritis Cartilage. 2011 Nov;19(11):1270-85
pubmed: 21907813
Injury. 2017 Dec;48 Suppl 7:S41-S46
pubmed: 28851523
Eur J Orthop Surg Traumatol. 2016 May;26(4):339-53
pubmed: 27028746
Osteoporos Int. 2004 Nov;15(11):897-902
pubmed: 15490120
Clin Orthop Relat Res. 2009 Mar;467(3):623-37
pubmed: 19037710
Acta Orthop Scand. 1980 Oct;51(5):803-10
pubmed: 7468173
J Bone Joint Surg Am. 1995 Jul;77(7):1058-64
pubmed: 7608228
Int Orthop. 2001;25(6):360-2
pubmed: 11820441
Nat Rev Dis Primers. 2016 Oct 13;2:16072
pubmed: 27734845
Ann Rheum Dis. 2004 Nov;63(11):1427-33
pubmed: 15479891

Auteurs

Charles A Gallagher (CA)

Department of Orthopaedics, Fremantle Hospital, Alma Street, Fremantle, WA, 6160, Australia. gallaghercharles@hotmail.com.

Christopher W Jones (CW)

Department of Orthopaedics, Fremantle Hospital, Alma Street, Fremantle, WA, 6160, Australia.

Lara Kimmel (L)

Department of Physiotherapy, The Alfred Hospital, Melbourne, VIC, Australia.
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Christopher Wylde (C)

Department of Orthopaedics, Fremantle Hospital, Alma Street, Fremantle, WA, 6160, Australia.

Anthony Osbrough (A)

Department of Orthopaedics, Fremantle Hospital, Alma Street, Fremantle, WA, 6160, Australia.

Max Bulsara (M)

Institute of Health Research, University of Notre Dame, Fremantle, WA, Australia.

Kathryn Hird (K)

School of Medicine, University of Notre Dame, Fremantle, WA, Australia.

Piers Yates (P)

Department of Orthopaedics, Fremantle Hospital, Alma Street, Fremantle, WA, 6160, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH